Evidence map›Paper›PMID 31814834›Full record

ArticleStem cells international2019

Improved Isolation of Mesenchymal Stem Cells Based on Interactions between

Hirohiko Ise, Kumiko Matsunaga, Marie Shinohara, Yasuyuki Sakai

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Intranasal administration of mesenchymal stem cells overexpressing FGF21 demonstrates therapeutic potential in experimental Parkinson's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Co-regulation ofFrontiers in medicine · 2023
    Article
  9. Article
  10. Article
  11. Mechanical and Non-Mechanical Functions of Filamentous and Non-Filamentous Vimentin.BioEssays : news and reviews in molecular, cellular and developmental biology · 2020
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hirohiko IseInstitute for Materials Chemistry and Engineering, Kyushu University, CE41-206, 744 Motooka Nishi-ku, Fukuoka 819-0395, Japan.ORCID https://orcid.org/0000-0002-4948-9375
Kumiko MatsunagaSomar Corp., 4-11-2 Ginza Chuo-ku, Tokyo 104-8109, Japan.
Marie ShinoharaInstitute of Industrial Science, The University of Tokyo, Fe505, 4-6-1 Komaba Meguro-ku, Tokyo 153-8505, Japan.ORCID https://orcid.org/0000-0003-0380-5632
Yasuyuki SakaiInstitute of Industrial Science, The University of Tokyo, Fe505, 4-6-1 Komaba Meguro-ku, Tokyo 153-8505, Japan.ORCID https://orcid.org/0000-0001-7734-5398
The University of Tokyo · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) in bone marrow and adipose tissues are expected to be effective tools for regenerative medicine to treat various diseases. To obtain MSCs that possess both high differentiation and tissue regenerative potential, it is necessary to establish an isolation system that does not require long-term culture. It has previously been reported that the cytoskeletal protein vimentin, expressed on the surfaces of multiple cell types, possesses

Identifiers

PMID31814834
PMCPMC6878802
OpenAlexW2986932968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.